Delivery Order SPE2DB24D1205-SPE2DB24FCSSC

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The $1,790.51 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,833.64 and an ultimate completion date of April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA). The $3,308.95 Firm Fixed Price delivery order is for the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with a period of performance through May 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA PEN 40 MG/0.8 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,790.21, has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract, valued at $12,330.12, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a completion date of June 4, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products. The $7,802.80 firm-fixed price delivery order has a completion date of November 21, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $4,565.10, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Humira(CF) Pen 40 mg/0.4 mls pharmaceutical product to the Defense Logistics Agency (DLA). The $2,770.74 firm fixed price delivery order has a completion date of July 11, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $6,288.06 Firm Fixed Price Delivery Order is for the supply of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,541.48, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which is the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSSC
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $34,431.99, has a performance period ending on July 12, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/10/24, 9:36 AM